Tirozinska proteinska kinaza HCK

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
edit
HCK proto-onkogen, Src familija tirozinskih kinaza

PDB prikaz baziran na 1ad5.
Dostupne strukture
1AD5, 1BU1, 1QCF, 2C0I, 2C0O, 2C0T, 2HCK, 2HK5, 2OI3, 2OJ2, 3HCK, 3NHN, 3RBB, 3REA, 3REB, 3VRY, 3VRZ, 3VS0, 3VS1, 3VS2, 3VS3, 3VS4, 3VS5, 3VS6, 3VS7, 4HCK, 4LUD, 4LUE, 4ORZ, 5HCK
Identifikatori
SimboliHCK; JTK9; p59Hck; p61Hck
Vanjski IDOMIM142370 MGI96052 HomoloGene20489 GeneCards: HCK Gene
EC broj2.7.10.2
Pregled RNK izražavanja
PBB GE HCK 208018 s at tn.png
podaci
Ortolozi
VrstaČovekMiš
Entrez305515162
EnsemblENSG00000101336ENSMUSG00000003283
UniProtP08631P08103
Ref. Sekv. (iRNK)NM_001172129NM_001172117
Ref. Sekv. (protein)NP_001165600NP_001165588
Lokacija (UCSC)Chr 20:
30.64 - 30.69 Mb
Chr 2:
153.11 - 153.15 Mb
PubMed pretraga[1][2]

Tirozinska proteinska kinaza HCK je enzim koji je kod ljudi kodiran HCK genom.[1]

Protein kodiran ovim genom je proteinska tirozincka kinaza koja je prodominantno izražena u hemopoetskim ćelijskim tipovima, i pripada Src familiji tirozinskih kinaza. Kodirani protein pomaže u formiranju respiratornih sprega Fc receptora. On takođe uzima učešća u neutrofilnoj migraciji i u degranulaciji neutrofila. Pozbate su dve alternativne splajsne varijante kojim se formiraju dve distinktne izoforme, koje imaju različite podćelijske lokalizacije.[2]

Interakcije[uredi - уреди | uredi izvor]

HCK formira interakcije sa BCR genom,[3][4] ELMO1,[5] Cbl genom,[6][7] RAS p21 proteinski aktivator 1,[8] RASA3,[8] receptorom faktora stimulacije granulocitnih kolonija,[9] ADAM15[10] i RAPGEF1.[11]

Reference[uredi - уреди | uredi izvor]

  1. Quintrell N, Lebo R, Varmus H, Bishop JM, Pettenati MJ, Le Beau MM, Diaz MO, Rowley JD (August 1987). "Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells". Mol Cell Biol 7 (6): 2267–75. PMC 365351. PMID 3496523. 
  2. "Entrez Gene: HCK hemopoietic cell kinase". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3055. 
  3. Stanglmaier, M; Warmuth M; Kleinlein I; Reis S; Hallek M (February 2003). "The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains". Leukemia (England) 17 (2): 283–9. ISSN 0887-6924. PMID 12592324. doi:10.1038/sj.leu.2402778. 
  4. Lionberger, J M; Wilson M B; Smithgall T E (June 2000). "Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck". J. Biol. Chem. (UNITED STATES) 275 (24): 18581–5. ISSN 0021-9258. PMID 10849448. doi:10.1074/jbc.C000126200. 
  5. Scott, Margaret Porter; Zappacosta Francesca; Kim Eun Young; Annan Roland S; Miller W Todd (August 2002). "Identification of novel SH3 domain ligands for the Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein (WIP), and ELMO1". J. Biol. Chem. (United States) 277 (31): 28238–46. ISSN 0021-9258. PMID 12029088. doi:10.1074/jbc.M202783200. 
  6. Howlett, Christopher J; Robbins Stephen M (March 2002). "Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation". Oncogene (England) 21 (11): 1707–16. ISSN 0950-9232. PMID 11896602. doi:10.1038/sj.onc.1205228. 
  7. Howlett, C J; Bisson S A; Resek M E; Tigley A W; Robbins S M (April 1999). "The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase". Biochem. Biophys. Res. Commun. (UNITED STATES) 257 (1): 129–38. ISSN 0006-291X. PMID 10092522. doi:10.1006/bbrc.1999.0427. 
  8. 8,0 8,1 Briggs, S D; Bryant S S; Jove R; Sanderson S D; Smithgall T E (June 1995). "The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck". J. Biol. Chem. (UNITED STATES) 270 (24): 14718–24. ISSN 0021-9258. PMID 7782336. doi:10.1074/jbc.270.24.14718. 
  9. Ward, A C; Monkhouse J L; Csar X F; Touw I P; Bello P A (October 1998). "The Src-like tyrosine kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF) and docks to the activated G-CSF receptor". Biochem. Biophys. Res. Commun. (UNITED STATES) 251 (1): 117–23. ISSN 0006-291X. PMID 9790917. doi:10.1006/bbrc.1998.9441. 
  10. Poghosyan, Zaruhi; Robbins Stephen M; Houslay Miles D; Webster Ailsa; Murphy Gillian; Edwards Dylan R (February 2002). "Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases". J. Biol. Chem. (United States) 277 (7): 4999–5007. ISSN 0021-9258. PMID 11741929. doi:10.1074/jbc.M107430200. 
  11. Shivakrupa, R; Radha Vegesna; Sudhakar Ch; Swarup Ghanshyam (December 2003). "Physical and functional interaction between Hck tyrosine kinase and guanine nucleotide exchange factor C3G results in apoptosis, which is independent of C3G catalytic domain". J. Biol. Chem. (United States) 278 (52): 52188–94. ISSN 0021-9258. PMID 14551197. doi:10.1074/jbc.M310656200. 

Literatura[uredi - уреди | uredi izvor]